Ahmed Yamany Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmed Yamany Ali has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Mervat Essam Behiry
Department of Internal Medicine, Faculty of Medicine, Cairo University, Kasr Alainy, Egypt
3 shared publications Amira Hassouna
AUT University
1 shared publication- Amul M. Badr
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo 12613, Egypt
1 shared publication - Basma M. Medhat
Rheumatology and Rehabilitation, Cairo University, Cairo, Egypt
1 shared publication - Dalia Dorgham
Rheumatology and Rehabilitation Department, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publication Dina Sabry
Cairo University
1 shared publication
Latest Publications
- Open Access
- 29 January 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 7
Correlation between serum Angiotensin II level and severity of COVID-19 disease
Background: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Angiotensin-converting enzyme 2 (ACE2) is a key player in the pathophysiology of COVID-19, as it facilitates the cellular viral entry, which in turn causes upregulation of Angiotensin II (Ang II) which correlates with the severity of infection and inflammation. Objectives: Assessing the serum levels of Ang-II among COVID-19 patients, and correlate it with disease severity. Patients and methods: Eighty patients of COVID- 19 and 80 healthy subjects were enrolled in this cross sectional study. COVID-19 patients was divided to 4 groups; mild, moderate, severe, and critical groups, according to WHO classification of severity of the disease .Beside clinical, laboratory (CBC, CRP, D-dimer, liver and kidney function tests) and imaging assessment, Ang II level was measured using ELISA kits. Results: Levels of Ang-II are significantly higher in COVID-19 patients (281.82 ± 114.54 pg/dl) compared to control (72.53 ± 21.86 pg/dl), with a p-value < 0.001. Significant higher levels were detected in severe and critical cases, which were 347.65 ± 37.70 and 436.06 ± 53.00, respectively, as compared to mild and moderate cases, which were 132.16 ± 27.98 and 216.44 ± 49.47 pg/dl, respectively. An ROC curve for detection of the cutoff value of Ang II level was 115.5 pg/dl with an AUC of 0.990. Moreover, a cutoff value of Ang II for determining the severe and critical cases was 300.05 pg/dl with an AUC of 1.000. Conclusion: Ang-II may be a potential biomarker that could aid in determining the severity of cases aiming at the development of therapeutic strategies to mitigate disease severity.
- 29 January 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 7
Open AccessCorrelation between serum Angiotensin II level and severity of COVID-19 disease
Background: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Angiotensin-converting enzyme 2 (ACE2) is a key player in the pathophysiology of COVID-19, as it facilitates the cellular viral entry, which in turn causes upregulation of Angiotensin II (Ang II) which correlates with the severity of infection and inflammation. Objectives: Assessing the serum levels of Ang-II among COVID-19 patients, and correlate it with disease severity. Patients and methods: Eighty patients of COVID- 19 and 80 healthy subjects were enrolled in this cross sectional study. COVID-19 patients was divided to 4 groups; mild, moderate, severe, and critical groups, according to WHO classification of severity of the disease .Beside clinical, laboratory (CBC, CRP, D-dimer, liver and kidney function tests) and imaging assessment, Ang II level was measured using ELISA kits. Results: Levels of Ang-II are significantly higher in COVID-19 patients (281.82 ± 114.54 pg/dl) compared to control (72.53 ± 21.86 pg/dl), with a p-value < 0.001. Significant higher levels were detected in severe and critical cases, which were 347.65 ± 37.70 and 436.06 ± 53.00, respectively, as compared to mild and moderate cases, which were 132.16 ± 27.98 and 216.44 ± 49.47 pg/dl, respectively. An ROC curve for detection of the cutoff value of Ang II level was 115.5 pg/dl with an AUC of 0.990. Moreover, a cutoff value of Ang II for determining the severe and critical cases was 300.05 pg/dl with an AUC of 1.000. Conclusion: Ang-II may be a potential biomarker that could aid in determining the severity of cases aiming at the development of therapeutic strategies to mitigate disease severity.
- 9 October 2025
- Published by SAGE Publications in Lupus
- Vol. 34 (13) , 1362-1368
Renal iron expression and urinary transferrin excretion in lupus nephritis: A case-control study
Background: Lupus nephritis (LN) is a key manifestation of systemic lupus erythematosus (SLE). Aim of the work: To assess urinary transferrin level, renal iron accumulation and transferrin receptor (TfR) gene expression in SLE. Patients and methods: A case-control study was conducted on 80 SLE patients (40 with LN and 40 without LN), and 90 age and sex matched healthy control. Iron markers (Serum iron, ferritin, TfR gene, and urinary transferrin) were assessed in all participants. Iron accumulation and TfR gene expression were evaluated in renal biopsy for LN cases. Disease activity was assessed by Systemic Lupus Erythematosus Disease Activity Index-2K(SLEDAI2k). Results: Of 80 patients, 85% were female. Mean SLEDAI was 15.0525 ± 1.1592, the disease duration was of mean 47.6 ± 26.56 months, and mean age was 31.32 ± 8.85. Serum and urinary iron biomarkers were significantly higher in SLE patients compared to controls except for iron which was lower in lupus patients with similar significant difference between patients subgroups. TfR gene expression in renal tissue didn’t significantly differ across LN classes. Tubular iron deposition was observed histopathologicaly. Urinary transferrin showed significant correlation with activity score and proteinuria (r = 0.94, r = 0.43 and p < .0001, p = .03) while serum TfR significantly correlated with disease activity and ESR (r = 0.61, r = 0.4 and p < .0001, p = .03, respectively). TfR gene expression on renal tissue did not correlate with urinary transferrin, disease activity or other laboratory parameters. Conclusions: Elevated urinary transferrin and serum TfR correlated with disease activity in lupus population and may serve as a potential non-invasive biomarker for lupus nephritis.
- 9 October 2025
- Published by SAGE Publications in Lupus
- Vol. 34 (13) , 1362-1368
Renal iron expression and urinary transferrin excretion in lupus nephritis: A case-control study
Background: Lupus nephritis (LN) is a key manifestation of systemic lupus erythematosus (SLE). Aim of the work: To assess urinary transferrin level, renal iron accumulation and transferrin receptor (TfR) gene expression in SLE. Patients and methods: A case-control study was conducted on 80 SLE patients (40 with LN and 40 without LN), and 90 age and sex matched healthy control. Iron markers (Serum iron, ferritin, TfR gene, and urinary transferrin) were assessed in all participants. Iron accumulation and TfR gene expression were evaluated in renal biopsy for LN cases. Disease activity was assessed by Systemic Lupus Erythematosus Disease Activity Index-2K(SLEDAI2k). Results: Of 80 patients, 85% were female. Mean SLEDAI was 15.0525 ± 1.1592, the disease duration was of mean 47.6 ± 26.56 months, and mean age was 31.32 ± 8.85. Serum and urinary iron biomarkers were significantly higher in SLE patients compared to controls except for iron which was lower in lupus patients with similar significant difference between patients subgroups. TfR gene expression in renal tissue didn’t significantly differ across LN classes. Tubular iron deposition was observed histopathologicaly. Urinary transferrin showed significant correlation with activity score and proteinuria (r = 0.94, r = 0.43 and p < .0001, p = .03) while serum TfR significantly correlated with disease activity and ESR (r = 0.61, r = 0.4 and p < .0001, p = .03, respectively). TfR gene expression on renal tissue did not correlate with urinary transferrin, disease activity or other laboratory parameters. Conclusions: Elevated urinary transferrin and serum TfR correlated with disease activity in lupus population and may serve as a potential non-invasive biomarker for lupus nephritis.
- 1 November 2023
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 19 (4) , 463-469
Evaluation of Immunity-related GTPase Family M Protein (IRGM) SNPs among Egyptian Lupus Patients: A Case-control Study
Objective: One of the potential factors that cause systemic lupus erythematosus (SLE) development is autophagy. Immunity-related GTPase family M protein (IRGM) has been shown to be linked to immune-mediated diseases. The aim of the current study was to assess the role of the IRGM-autophagy gene in SLE susceptibility in an Egyptian population and its relation to lupus nephritis. Methods: A case-control study was conducted in which a total of 200 subjects (100SLE and 100 healthy controls) were enrolled. Two single-nucleotide polymorphisms (SNPs) (rs10065172 and rs4958847) were genotyped. Genotypes and alleles analysis was conducted to compare between cases and controls, as well as a stratification analysis was conducted on the presence or absence of lupus nephritis. Results: Among selected SNPs of IRGM, no association was found between both SNPs and SLE susceptibility. For rs10065172, the major expressed genotype was CC (61% and 71%) (Adj OR= 2.9, 95%= 0.545-15.5), followed by TC (34 % and 27%) (Adj OR= 1.985, 95%= 0.357-11.041) in cases and controls, respectively. For rs4958847, AA and AG were comparably expressed in case [(43% and 39%) (Adj OR= 1.073, 95%= 0.483-2.382)] and control [(41% and 43%) (Adj OR= 1.24, 95%= 0.557- 2.763)], respectively. Additionally, no relationship among both SNPs and gender, lupus nephritis, disease activity, or disease duration, was observed. Conclusion: IRGM SNPs (rs10065172 and rs4958847) expression was comparable among SLE patients and controls of the Egyptian cohort. Genotype and allele frequency of IRGM SNPs did not differ in lupus nephritis and non-lupus nephritis patients.
- 1 November 2023
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 19 (4) , 463-469
Evaluation of Immunity-related GTPase Family M Protein (IRGM) SNPs among Egyptian Lupus Patients: A Case-control Study
Objective: One of the potential factors that cause systemic lupus erythematosus (SLE) development is autophagy. Immunity-related GTPase family M protein (IRGM) has been shown to be linked to immune-mediated diseases. The aim of the current study was to assess the role of the IRGM-autophagy gene in SLE susceptibility in an Egyptian population and its relation to lupus nephritis. Methods: A case-control study was conducted in which a total of 200 subjects (100SLE and 100 healthy controls) were enrolled. Two single-nucleotide polymorphisms (SNPs) (rs10065172 and rs4958847) were genotyped. Genotypes and alleles analysis was conducted to compare between cases and controls, as well as a stratification analysis was conducted on the presence or absence of lupus nephritis. Results: Among selected SNPs of IRGM, no association was found between both SNPs and SLE susceptibility. For rs10065172, the major expressed genotype was CC (61% and 71%) (Adj OR= 2.9, 95%= 0.545-15.5), followed by TC (34 % and 27%) (Adj OR= 1.985, 95%= 0.357-11.041) in cases and controls, respectively. For rs4958847, AA and AG were comparably expressed in case [(43% and 39%) (Adj OR= 1.073, 95%= 0.483-2.382)] and control [(41% and 43%) (Adj OR= 1.24, 95%= 0.557- 2.763)], respectively. Additionally, no relationship among both SNPs and gender, lupus nephritis, disease activity, or disease duration, was observed. Conclusion: IRGM SNPs (rs10065172 and rs4958847) expression was comparable among SLE patients and controls of the Egyptian cohort. Genotype and allele frequency of IRGM SNPs did not differ in lupus nephritis and non-lupus nephritis patients.
- Open Access
- 1 January 2023
- Published by Egyptian Knowledge Bank in The Egyptian Journal of Hospital Medicine
- Vol. 90 (1) , 1862-1868
Transforming Growth Factor- Beta1 in Relation to Glomerular Filtration Rate in Healthy Elderly Egyptians
Background: Owing to high burdens ofchronic kidney disease (CKD) worldwide, research targeting early detection of impaired kidney function merits attention. Transforming growth factor-β1 levels (TGF- β1) regulates renal fibrosis and rises in different kidney diseases. Objectives: The present study aimed at evaluating the serum level of TGF- β1 in relation to estimated glomerular filtration rate (eGFR) in elderly healthy individuals. Methods: This cross-sectional study included 55 individuals, aged above 60 years. Serum level of TGF- β1, microalbuminuria and eGFR were estimated. Systolic and diastolic blood pressure were measured. Results: There was a significant negative correlation between GFR and TGF-β1 values (r value= -0.731, P = 0.001). Twenty-four hours urinary proteins and TGF-β1 levels showed a positive significant correlation (r-value = 0.713, p < 0.001). There was no statistically significant difference in TGF- β1 values between males and females (P = 0.832). TGF-B showed good sensitivity: 90.7%; poor specificity: 41.7% at a cut-off of 41.5 with AUC: 0.85; p value < 0.001 to be an indicator for reduced e GFR. Conclusions: TGF- β1 levels could be a potential marker for early detection of renal diseases in elderly individuals.
- 1 January 2023
- Published by Egyptian Knowledge Bank in The Egyptian Journal of Hospital Medicine
- Vol. 90 (1) , 1862-1868
Open AccessTransforming Growth Factor- Beta1 in Relation to Glomerular Filtration Rate in Healthy Elderly Egyptians
Background: Owing to high burdens ofchronic kidney disease (CKD) worldwide, research targeting early detection of impaired kidney function merits attention. Transforming growth factor-β1 levels (TGF- β1) regulates renal fibrosis and rises in different kidney diseases. Objectives: The present study aimed at evaluating the serum level of TGF- β1 in relation to estimated glomerular filtration rate (eGFR) in elderly healthy individuals. Methods: This cross-sectional study included 55 individuals, aged above 60 years. Serum level of TGF- β1, microalbuminuria and eGFR were estimated. Systolic and diastolic blood pressure were measured. Results: There was a significant negative correlation between GFR and TGF-β1 values (r value= -0.731, P = 0.001). Twenty-four hours urinary proteins and TGF-β1 levels showed a positive significant correlation (r-value = 0.713, p < 0.001). There was no statistically significant difference in TGF- β1 values between males and females (P = 0.832). TGF-B showed good sensitivity: 90.7%; poor specificity: 41.7% at a cut-off of 41.5 with AUC: 0.85; p value < 0.001 to be an indicator for reduced e GFR. Conclusions: TGF- β1 levels could be a potential marker for early detection of renal diseases in elderly individuals.
- Open Access
- 1 January 2021
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 14, 141-152
Impact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial
Purpose: Few data are available on the positive impact of photo-biomodulation (PBM) using low-level laser therapy as a complementary treatment for improving the cognitive function and optimizing the hemoglobin (Hb) level and oxygen carrying capacity in anemic elderly patients and consequently improving the quality-of-life. The present study aimed to evaluate a new, safe, and easy therapeutic approach to improve Alzheimer’s disease-related symptoms that interfere with the whole life activities and social interaction of elderly patients. Patients and Methods: In this placebo-controlled clinical trial, 60 elderly patients suffering from anemia and mild cognitive dysfunction were randomly assigned into two equal groups to receive active or placebo low-level laser in addition to a moderate-intensity aerobic exercise over a 12-week period. Hb level as well as cognitive and functional tests were reassessed for any change after 12 weeks of intervention. Results: By the end of this study, both groups showed significant improvements in Hb level, Montreal Cognitive Assessment Scale (MoCa – B basic), Quality-of-Life for Alzheimer’s Disease scale, and Berg Balance scale scores along with significant reduction in body mass index (BMI) and waist–hip ratio (WHR) (P< 0.0001). The experimental group which received active low-level laser in addition to moderate-intensity aerobic exercise showed more significant results compared to the control group which received placebo low-level laser in addition to moderate-intensity aerobic exercise in all the measured outcomes (P< 0.001). Conclusion: Combined low-level laser therapy and moderate-intensity aerobic exercises are more effective in improving the cognitive function and quality-of-life of Alzheimer’s disease patients. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT04496778.
- 1 January 2021
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 14, 141-152
Open AccessImpact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial
Purpose: Few data are available on the positive impact of photo-biomodulation (PBM) using low-level laser therapy as a complementary treatment for improving the cognitive function and optimizing the hemoglobin (Hb) level and oxygen carrying capacity in anemic elderly patients and consequently improving the quality-of-life. The present study aimed to evaluate a new, safe, and easy therapeutic approach to improve Alzheimer’s disease-related symptoms that interfere with the whole life activities and social interaction of elderly patients. Patients and Methods: In this placebo-controlled clinical trial, 60 elderly patients suffering from anemia and mild cognitive dysfunction were randomly assigned into two equal groups to receive active or placebo low-level laser in addition to a moderate-intensity aerobic exercise over a 12-week period. Hb level as well as cognitive and functional tests were reassessed for any change after 12 weeks of intervention. Results: By the end of this study, both groups showed significant improvements in Hb level, Montreal Cognitive Assessment Scale (MoCa – B basic), Quality-of-Life for Alzheimer’s Disease scale, and Berg Balance scale scores along with significant reduction in body mass index (BMI) and waist–hip ratio (WHR) (P< 0.0001). The experimental group which received active low-level laser in addition to moderate-intensity aerobic exercise showed more significant results compared to the control group which received placebo low-level laser in addition to moderate-intensity aerobic exercise in all the measured outcomes (P< 0.001). Conclusion: Combined low-level laser therapy and moderate-intensity aerobic exercises are more effective in improving the cognitive function and quality-of-life of Alzheimer’s disease patients. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT04496778.
- Open Access
- 1 March 2020
- Published by Taylor & Francis in Open Access Rheumatology: Research and Reviews
- Vol. ume 12, 29-34
Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study
Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with multi-organ involvement. Hyponatremia is common in inflammatory diseases such as meningitis. Also, it has been found to be strongly associated with the degree of inflammation. However, it has not been fully evaluated in lupus. This study aimed to assess the inflammatory impact of hyponatremia in SLE patients and investigate its relationship with SLE disease activity. Patients and Methods: A total of 101 patients with SLE were enrolled in this study and divided into two groups according to Na level; a normo-natremic group and a hyponatremic group. Demographic and clinical data were collected. SLE activity was assessed by the systemic lupus erythematosus disease activity index (SLEDAI). The estimated sedimentation rate (ESR) as well as levels of C-reactive protein (CRP) and complements (C3 and C4) were measured. Results: The majority of patients were females (98 subjects) (97%) with a mean age of 33± 8 years. Out of 101 participants, 40 patients (39.6%) were hyponatremic with a mean Na level of 131.58± 3.11 mmol/L. There was a statistically negative correlation between both ESR and SLEADI score and Na level (r=− 0.436 and − 0.436, respectively) with p=0.002, whereas Na level was positively correlated with complements, Cl, and albumin levels (r=0.653, 0.314, and 0.460, respectively) (p=0.000, 0.027, and > 0.001, respectively). CRP was not correlated with Na level. ESR was independently correlated with hyponatremia at the 95% CI for Exp B (0.997– 0.058) with a p-value of 0.048. Conclusion: Hyponatremia could be used as an indicator of SLE activity. Also, it might be an easily and rapidly detected as well as a prognostically useful marker of inflammation.
- 1 March 2020
- Published by Taylor & Francis in Open Access Rheumatology: Research and Reviews
- Vol. ume 12, 29-34
Open AccessHyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study
Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with multi-organ involvement. Hyponatremia is common in inflammatory diseases such as meningitis. Also, it has been found to be strongly associated with the degree of inflammation. However, it has not been fully evaluated in lupus. This study aimed to assess the inflammatory impact of hyponatremia in SLE patients and investigate its relationship with SLE disease activity. Patients and Methods: A total of 101 patients with SLE were enrolled in this study and divided into two groups according to Na level; a normo-natremic group and a hyponatremic group. Demographic and clinical data were collected. SLE activity was assessed by the systemic lupus erythematosus disease activity index (SLEDAI). The estimated sedimentation rate (ESR) as well as levels of C-reactive protein (CRP) and complements (C3 and C4) were measured. Results: The majority of patients were females (98 subjects) (97%) with a mean age of 33± 8 years. Out of 101 participants, 40 patients (39.6%) were hyponatremic with a mean Na level of 131.58± 3.11 mmol/L. There was a statistically negative correlation between both ESR and SLEADI score and Na level (r=− 0.436 and − 0.436, respectively) with p=0.002, whereas Na level was positively correlated with complements, Cl, and albumin levels (r=0.653, 0.314, and 0.460, respectively) (p=0.000, 0.027, and > 0.001, respectively). CRP was not correlated with Na level. ESR was independently correlated with hyponatremia at the 95% CI for Exp B (0.997– 0.058) with a p-value of 0.048. Conclusion: Hyponatremia could be used as an indicator of SLE activity. Also, it might be an easily and rapidly detected as well as a prognostically useful marker of inflammation.
- 1 September 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (7) , 2425-2429
Effect of Duration of Intensive Care Unit Stay on Outcomes of Adult Living Donor Liver Transplant Recipients
- 1 September 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (7) , 2425-2429
Effect of Duration of Intensive Care Unit Stay on Outcomes of Adult Living Donor Liver Transplant Recipients
- Open Access
- 15 June 2019
- Published by Science Insights in Pakistan Journal of Nutrition
- Vol. 18 (7) , 650-656
Short Nutritional Assessment Questionnaire as a Malnutrition Screening Tool for Hospitalized Patients
Background and Objective: Nutritional screening upon hospital admission is important to ensure prompt and effective interventional management and to reduce the incidence of hospital complications. This study aimed to screen and evaluate the nutritional status of patients admitted to a tertiary care centre using the Short Nutritional Assessment Questionnaire (SNAQ) and to assess the relationship between malnutrition and length of hospital stay. Materials and Methods: One thousand patients were recruited from the medical wards of Kasr Al Ainy Hospital. All enrolled patients were screened for malnutrition using the SNAQ. Body mass index (BMI), haemoglobin and albumin levels were measured. The predictors of hospital stay were assessed. Results: Of the 1000 patients, 522 (52.2%) were male and their ages ranged from 18-97 years. The median (IQR) BMI was 25.9 (22.8-29.4). A total of 550 patients were malnourished, with SNAQ scores ≥2. The frequency of anaemia and hypoalbuminemia differed significantly in malnourished patients (SNAQ≥2) from that in non-malnourished patients (p<0.001). A long hospital stay was significantly associated with higher SNAQ scores (r = 0.318, p≤0.001) and was inversely associated with BMI and albumin, while a low BMI was the most independent predictor of a long hospital stay (95% CI for the beta coefficient=0.125-0.033). Conclusion: The SNAQ is a simple and quick tool for screening malnutrition risk among hospitalized patients.
- 15 June 2019
- Published by Science Insights in Pakistan Journal of Nutrition
- Vol. 18 (7) , 650-656
Open AccessShort Nutritional Assessment Questionnaire as a Malnutrition Screening Tool for Hospitalized Patients
Background and Objective: Nutritional screening upon hospital admission is important to ensure prompt and effective interventional management and to reduce the incidence of hospital complications. This study aimed to screen and evaluate the nutritional status of patients admitted to a tertiary care centre using the Short Nutritional Assessment Questionnaire (SNAQ) and to assess the relationship between malnutrition and length of hospital stay. Materials and Methods: One thousand patients were recruited from the medical wards of Kasr Al Ainy Hospital. All enrolled patients were screened for malnutrition using the SNAQ. Body mass index (BMI), haemoglobin and albumin levels were measured. The predictors of hospital stay were assessed. Results: Of the 1000 patients, 522 (52.2%) were male and their ages ranged from 18-97 years. The median (IQR) BMI was 25.9 (22.8-29.4). A total of 550 patients were malnourished, with SNAQ scores ≥2. The frequency of anaemia and hypoalbuminemia differed significantly in malnourished patients (SNAQ≥2) from that in non-malnourished patients (p<0.001). A long hospital stay was significantly associated with higher SNAQ scores (r = 0.318, p≤0.001) and was inversely associated with BMI and albumin, while a low BMI was the most independent predictor of a long hospital stay (95% CI for the beta coefficient=0.125-0.033). Conclusion: The SNAQ is a simple and quick tool for screening malnutrition risk among hospitalized patients.